Cannabinoid type 1 receptor binding proteins and uses thereof

Described herein are anti-CB1 (e.g., huCB1) antibodies and antigen binding fragments, compositions comprising the same and their use for the treatment of various disorders or diseases such as obesity and its comorbidities, chronic kidney disease, liver disease (e.g., NAFLD), and NASH.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHEN, IRWIN, PASUMARTHI, VENKATA NIHAL, MATOCHIKO, WADIM L, BERGEN, JOHN, CHONG, SU, LI, SERINA, OXENOID, KIRILL, VENIANT-ELLISON, MURIELLE MARIE, KILLION, ELIZABETH ANN, HAN, SEOG JOON, LU, SHUN, WEISHUHN, DAWN, CHEN, WEIHSU CLAIRE
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Described herein are anti-CB1 (e.g., huCB1) antibodies and antigen binding fragments, compositions comprising the same and their use for the treatment of various disorders or diseases such as obesity and its comorbidities, chronic kidney disease, liver disease (e.g., NAFLD), and NASH.